Skip to main content

Want a detailed portfolio tracker?

Argen X (ARGX) P/E (2017 - 2026)

Argen X (ARGX) P/E from May 18, 2017 to Jul 21, 2026. The TTM Argen X (ARGX) P/E is 24.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Argen X (ARGX)

YearP/EChange
202624.63-6.51%
202526.35-46.57%
202449.31-197.99%
2023-50.32+249.28%
2022-14.41-41.68%
2021-24.71-2.51%
2020-25.34-28.21%
2019-35.30+21.32%
2018-29.09-1.23%
2017-29.46N/A

Comparison Argen X (ARGX) P/E with competitors

Argen X (ARGX) P/E is 24.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.70%
FGENFibroGen Inc0.24-99.03%
CHRSCoherus Biosciences Inc0.85-96.56%
FBIOFortress Biotech Inc0.95-96.15%
ORMPOramed Pharmaceuticals Inc1.50-93.90%
AGENAgenus Inc3.01-87.78%
INVAInnoviva Inc3.15-87.20%
VXRTVaxart Inc3.55-85.59%
CRMDCorMedix Inc3.63-85.27%
CVACCureVac N.V.4.45-81.95%
GLPGGalapagos NV4.86-80.27%
SRPTSarepta Therapeutics Inc4.88-80.18%
ABEOAbeona Therapeutics Inc5.39-78.13%
ABUSArbutus Biopharma Corp5.60-77.28%
ZVRAZevra Therapeutics Inc5.89-76.10%
SPROSpero Therapeutics Inc6.23-74.71%
CGENCompugen Ltd6.31-74.37%
RIGLRigel Pharmaceuticals6.87-72.10%
SLXNSilexion Therapeutics Corp7.30-70.38%
OMEROmeros Corporation9.26-62.41%
AUPHAurinia Pharmaceuticals Inc9.58-61.09%
PLXProtalix BioTherapeutics Inc10.89-55.78%
ACADAcadia Pharmaceuticals Inc11.73-52.38%
TBPHTheravance Biopharma Inc12.26-50.22%
ADMAAdma Biologics Inc12.42-49.58%
HRMYHarmony Biosciences Holdings Inc13.82-43.89%
SABSSAB Biotherapeutics Inc14.14-42.61%
NAGENiagen Bioscience Inc14.82-39.84%
INCYIncyte Corp15.82-35.76%
REGNRegeneron Pharmaceuticals Inc15.86-35.62%
PBYIPuma Biotechnology Inc17.32-29.70%
CPRXCatalyst Pharmaceuticals Inc17.44-29.20%
EXELExelixis Inc17.54-28.80%
TGTXTG Therapeutics Inc18.97-23.00%
MDXGMimedx Group Inc20.55-16.56%
XOMAXOMA Royalty Corp22.87-7.13%
CTMXCytomX Therapeutics Inc24.82+0.77%
XOMAOXOMA Royalty Corp25.34+2.90%
HALOHalozyme Therapeutics Inc25.62+4.03%
XOMAPXOMA Royalty Corp25.67+4.22%
VRTXVertex Pharmaceuticals Inc27.99+13.66%
RPRXRoyalty Pharma plc - Class A28.69+16.47%
SLNOSoleno Therapeutics Inc29.02+17.80%
ASNDAscendis Pharma A/S30.09+22.15%
LGNDLigand Pharmaceuticals Inc - Class B37.91+53.92%
APLSApellis Pharmaceuticals Inc39.02+58.43%
BMRNBiomarin Pharmaceutical Inc42.21+71.38%
KRYSKrystal Biotech Inc45.34+84.09%
ONCBeiGene Ltd69.54+182.33%
PHARPharming Group N.V.75.03+204.60%
TECHBio-Techne Corp101.96+313.95%
VCELVericel Corp109.92+346.28%
ALNYAlnylam Pharmaceuticals Inc117.96+378.94%
GMABGenmab140.29+469.58%
TLXTelix Pharmaceuticals Ltd162.15+558.34%
CORTCorcept Therapeutics Inc212.86+764.20%